Your browser doesn't support javascript.
Call to action: how can the US Ending the HIV Epidemic initiative succeed?
Beyrer, Chris; Adimora, Adaora A; Hodder, Sally L; Hopkins, Ernest; Millett, Greg; Mon, Sandra Hsu Hnin; Sullivan, Patrick S; Walensky, Rochelle P; Pozniak, Anton; Warren, Mitchell; Richman, Bruce; Copeland, Raniyah; Mayer, Kenneth H.
  • Beyrer C; Center for Public Health and Human Rights, Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA. Electronic address: cbeyrer@jhu.edu.
  • Adimora AA; Department of Epidemiology, Gillings School of Public Health, University of North Carolina, Chapel Hill, NC, USA.
  • Hodder SL; Section of Infectious Diseases, School of Medicine, West Virginia University, Morgantown, WV, USA.
  • Hopkins E; San Francisco AIDS Foundation, San Francisco, CA, USA.
  • Millett G; Foundation for AIDS Research (amfAR), Washington, DC, USA.
  • Mon SHH; Center for Public Health and Human Rights, Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
  • Sullivan PS; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
  • Walensky RP; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.
  • Pozniak A; Department of HIV, Chelsea and Westminster Hospital NHS Trust, London, UK.
  • Warren M; AIDS Vaccine Advocacy Coalition (AVAC), New York, NY, USA.
  • Richman B; Prevention Access Campaign, New York, NY, USA.
  • Copeland R; Black AIDS Institute, Los Angeles, CA, USA.
  • Mayer KH; Beth Israel Deaconess Medical Center, Harvard Medical School, Fenway Health, Boston, MA, USA.
Lancet ; 397(10279): 1151-1156, 2021 03 20.
Article in English | MEDLINE | ID: covidwho-1087331
ABSTRACT
With more than 1·2 million people living with HIV in the USA, a complex epidemic across the large and diverse country, and a fragmented health-care system marked by widening health disparities, the US HIV epidemic requires sustained scientific and public health attention. The epidemic has been stubbornly persistent; high incidence densities have been sustained over decades and the epidemic is increasingly concentrated among racial, ethnic, and sexual and gender minority communities. This fact remains true despite extraordinary scientific advances in prevention, treatment, and care-advances that have been led, to a substantial degree, by US-supported science and researchers. In this watershed year of 2021 and in the face of the COVID-19 pandemic, it is clear that the USA will not meet the stated goals of the National HIV/AIDS Strategy, particularly those goals relating to reductions in new infections, decreases in morbidity, and reductions in HIV stigma. The six papers in the Lancet Series on HIV in the USA have each examined the underlying causes of these challenges and laid out paths forward for an invigorated, sustained, and more equitable response to the US HIV epidemic than has been seen to date. The sciences of HIV surveillance, prevention, treatment, and implementation all suggest that the visionary goals of the Ending the HIV Epidemic initiative in the USA might be achievable. However, fundamental barriers and challenges need to be addressed and the research effort sustained if we are to succeed.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Public Health Administration / HIV Infections / Epidemics / Health Plan Implementation Type of study: Observational study / Randomized controlled trials Limits: Humans Language: English Journal: Lancet Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Public Health Administration / HIV Infections / Epidemics / Health Plan Implementation Type of study: Observational study / Randomized controlled trials Limits: Humans Language: English Journal: Lancet Year: 2021 Document Type: Article